UNSPSC 51283003: Clindamycin hydrochloride

This classification denotes a lincosamide antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T20OQ1YN1W. European Medicines Agency schedules Clindamycin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01342MIG. Clindamycin hydrochloride generally arises in the molecular formula C18H33CLN2O5S.CLH. The term 'clindamycin hydrochloride' is a U.S. Pharmacopeial Convention designation.

UNSPSC 51283003 Clindamycin hydrochloride is a Commodity code that nominally designates a specific antibiotic pharmaceutical product, but the recent state and local solicitations tagged with this code show minimal alignment with clindamycin procurement itself. The opportunities instead span broader pharmaceutical and medical supply sourcing — including naloxone (an opioid antagonist), safe drug deactivation systems, generic multi-source pharmaceuticals, over-the-counter products, and emergency medical consumables. State and local governments are using this code to solicit pharmaceutical products and medical supplies through competitive bidding (IFB), requests for information (RFI), and requests for proposal (RFP) mechanisms. Issuing bodies include county health departments (Seminole County, Florida), state health commissions (Texas Health and Human Services Commission), municipal fire and rescue services (City of Tampa), and cooperative purchasing alliances serving multistate networks (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and participating jurisdictions). The work reflects routine procurement of medical inventory and pharmaceutical distribution capacity rather than procurement of clindamycin hydrochloride specifically.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026; due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery requirements; the City of Tampa's ITB 26-P-00145 (posted March 25, 2026; due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000.00 and sheltered for certified Small Local Business Enterprises with a 5 percent bid discount; the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026; due April 3, 2026) seeking vendor capabilities for direct-to-manufacturer prescription programs; and MMCAP's RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) for generic pharmaceuticals and OTC products to be distributed across state and local facilities in multiple states, with contract effectiveness July 1, 2026. This code exhibits significant scope mismatch with its nominal pharmaceutical designation and shows limited activity genuinely targeting clindamycin hydrochloride procurement.